Literature DB >> 29966614

Acute hepatitis E in French patients and neurological manifestations.

Florence Abravanel1, Julie Pique2, Elisabeth Couturier3, Florence Nicot4, Chloé Dimeglio5, Sébastien Lhomme6, Julie Chiabrando4, Karine Saune6, Jean-Marie Péron7, Nassim Kamar8, Solène Evrard9, Henriette de Valk3, Pascal Cintas2, Jacques Izopet6.   

Abstract

OBJECTIVES: Hepatitis E virus (HEV) is a major cause of acute hepatitis worldwide. However, our understanding of the source of contamination is incomplete and the frequency of neurological manifestations in still unknown.
METHODS: 200 eligible cases reported to the French National Reference Center from January 2015 to December 2015 were prospectively included in this case-control study (1 case: 1 control, matched for sex, age and area of living) to investigate the risk of infection. We documented the factors associated with their HEV infection and clinical manifestations.
RESULTS: The 200 HEV-infected patients included 137 who were immunocompetent and 63 immunocompromised. The factors associated with an HEV infection were contact with farm animals, eating pork liver sausage and eating unpeeled fruit. The 33 patients (16.5%) who reported neurological symptoms included 14 with neuropathic pain suggesting small fiber neuropathy, 9 with painless sensory disorders, 6 with Parsonage-Turner syndrome, one Guillain-Barre syndrome, one meningitis, one encephalitis and one diplopia. Neurological manifestations were more frequent in immunocompetent patients (22.6% vs 3.2%, p < 0.001).
CONCLUSIONS: This study highlights the risk of HEV transmission by the environment in industrialized countries. The higher frequency of neurological disorders in immunocompetent patients suggests pathophysiological mechanisms involving the immune system.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hepatitis E virus; Neurological manifestations; Risk factors

Mesh:

Year:  2018        PMID: 29966614     DOI: 10.1016/j.jinf.2018.06.007

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  15 in total

1.  Seroprevalence of hepatitis E virus (HEV) in a general adult population in Northern Norway: the Tromsø study.

Authors:  Irene Beate Olsøy; Stian Henriksen; Fabian H Weissbach; Marthe Larsen; Karoline Borgen; Florence Abravanel; Nassim Kamar; Eyvind J Paulssen; Hans H Hirsch; Christine Hanssen Rinaldo
Journal:  Med Microbiol Immunol       Date:  2019-03-22       Impact factor: 3.402

2.  Hepatitis E virus infects brain microvascular endothelial cells, crosses the blood-brain barrier, and invades the central nervous system.

Authors:  Debin Tian; Wen Li; C Lynn Heffron; Bo Wang; Hassan M Mahsoub; Harini Sooryanarain; Anna M Hassebroek; Sherrie Clark-Deener; Tanya LeRoith; Xiang-Jin Meng
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-07       Impact factor: 12.779

Review 3.  Review of clinical characteristics, immune responses and regulatory mechanisms of hepatitis E-associated liver failure.

Authors:  Chong Chen; Shu-Ye Zhang; Liang Chen
Journal:  World J Clin Cases       Date:  2022-07-06       Impact factor: 1.534

4.  Brain Infection by Hepatitis E Virus Probably via Damage of the Blood-Brain Barrier Due to Alterations of Tight Junction Proteins.

Authors:  Jijing Tian; Ruihan Shi; Tianlong Liu; Ruiping She; Qiaoxing Wu; Junqing An; Wenzhuo Hao; Majid Hussain Soomro
Journal:  Front Cell Infect Microbiol       Date:  2019-03-19       Impact factor: 5.293

5.  Hepatitis E virus infections in patients with MS on oral disease-modifying treatment.

Authors:  Martin Diebold; Bettina Fischer-Barnicol; Charidimos Tsagkas; Jens Kuhle; Ludwig Kappos; Tobias Derfuss; Bernhard F Décard
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-07-11

6.  Hepatitis E Infection in HIV-Infected Patients.

Authors:  Antonio Rivero-Juarez; Pedro Lopez-Lopez; Mario Frias; Antonio Rivero
Journal:  Front Microbiol       Date:  2019-06-26       Impact factor: 5.640

Review 7.  Hepatitis E virus-associated Guillain-Barre syndrome: Revision of the literature.

Authors:  Hang Liu; Ying Ma
Journal:  Brain Behav       Date:  2019-12-11       Impact factor: 2.708

Review 8.  Clinical Manifestations, Pathogenesis and Treatment of Hepatitis E Virus Infections.

Authors:  Sébastien Lhomme; Olivier Marion; Florence Abravanel; Jacques Izopet; Nassim Kamar
Journal:  J Clin Med       Date:  2020-01-24       Impact factor: 4.241

9.  Standardising surveillance of hepatitis E virus infection in the EU/EEA: A review of national practices and suggestions for the way forward.

Authors:  Cornelia Adlhoch; Zdenka Manďáková; Steen Ethelberg; Jevgenia Epštein; Ruska Rimhanen-Finne; Julie Figoni; Sally A Baylis; Mirko Faber; Kassiani Mellou; Niamh Murphy; Joanne O'Gorman; Maria Elena Tosti; Anna Rita Ciccaglione; Agnetha Hofhuis; Hans Zaaijer; Heidi Lange; Rita de Sousa; Ana Avellón; Lena Sundqvist; Bengü Said; Samreen Ijaz
Journal:  J Clin Virol       Date:  2019-09-19       Impact factor: 3.168

Review 10.  Extrahepatic manifestations of hepatitis E virus: An overview.

Authors:  Fotios S Fousekis; Ioannis V Mitselos; Dimitrios K Christodoulou
Journal:  Clin Mol Hepatol       Date:  2019-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.